A study published in the British Journal of Pharmacology on 3 March, led by University of Queensland researchers Associate Professor Trent Woodruff and Dr John Lee, has found the drug “PMX205” extends the life of mice that have a SOD1 mutation, when administered before or during very early disease onset. More studies are now underway to determine the safety of PMX205 before it can be tested in humans. 'Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis' tttp://onlinelibrary.wiley.com/doi/10.1111/bph.13730/full
Postive results for PMX205 in mice with SOD1 mutation
Latest News
Merriwa Trivia Night 2026
We'd like to thank the organisers of Let's Party Merriwa, who hosted a trivia night recently in the leadup to the event. What a fantastic night of fun...
Nicole is taking part in Walk to Defeat MND Port Macquarie - will you join her for a good cause?
Since her mum was diagnosed with motor neurone disease over a year ago, Port Macquarie local Nicole Potter has supported MND NSW by joining local Walk...
Thank you to our Community Fundraisers
We've seen some amazing community spirit shown by our supporters, who have been very busy raising awareness and much-needed funds to assist families f...
Will you join Cathy at Walk to Defeat MND Port Macquarie?
Wauchope local Cathy Eggert has been stepping up to support MND NSW since her brother Tim was diagnosed with motor neurone disease four years ago. She...